NCI Official Says Public Health Issue As Important As Data In Mammography
In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award
Generic Drug Makers Set Sights In Taxol Worldwide Market
Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain
White House Order Poses Difficulties For NIH Peer Review
NCI Cancer Education Program To Open To Innovative Ideas
NCI To Hold Symposium To Honor Wener Kirsten
AACR honors Five With Awards Next Month
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
